Literature DB >> 21062285

Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1.

Owen A Brady1, Peter Meng, Yanqiu Zheng, Yuxin Mao, Fenghua Hu.   

Abstract

TAR DNA-binding protein-43 (TDP-43) proteinopathy has been linked to several neurodegenerative diseases, such as frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Phosphorylated and ubiquitinated TDP-43 C-terminal fragments have been found in cytoplasmic inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis patients. However, the factors and pathways that regulate TDP-43 aggregation are still not clear. We found that the C-terminal 15 kDa fragment of TDP-43 is sufficient to induce aggregation but the aggregation phenotype is modified by additional sequences. Aggregation is accompanied by phosphorylation at serine residues 409/410. Mutation of 409/410 to phosphomimetic aspartic acid residues significantly reduces aggregation. Inhibition of either proteasome or autophagy dramatically increases TDP-43 aggregation. Furthermore, TDP-43 aggregates colocalize with markers of autophagy and the adaptor protein p62/SQSTM1. Over-expression of p62/SQSTM1 reduces TDP-43 aggregation in an autophagy and proteasome-dependent manner. These studies suggest that aggregation of TDP-43 C-terminal fragments is regulated by phosphorylation events and both the autophagy and proteasome-mediated degradation pathways.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062285     DOI: 10.1111/j.1471-4159.2010.07098.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

Review 2.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

Review 3.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

4.  Molecular chaperone HSP70 prevents formation of inclusion bodies of the 25-kDa C-terminal fragment of TDP-43 by preventing aggregate accumulation.

Authors:  Akira Kitamura; Nodoka Iwasaki; Masataka Kinjo
Journal:  Cell Stress Chaperones       Date:  2018-08-11       Impact factor: 3.667

5.  Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease.

Authors:  Liang Zhou; Hongfeng Wang; Haigang Ren; Qingsong Hu; Zheng Ying; Guanghui Wang
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

6.  The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.

Authors:  Nicole F Liachko; Aleen D Saxton; Pamela J McMillan; Timothy J Strovas; Heather N Currey; Laura M Taylor; Jeanna M Wheeler; Adrian L Oblak; Bernardino Ghetti; Thomas J Montine; C Dirk Keene; Murray A Raskind; Thomas D Bird; Brian C Kraemer
Journal:  Acta Neuropathol       Date:  2016-07-29       Impact factor: 17.088

Review 7.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

8.  p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies.

Authors:  Yuji Saitoh; Nobuhiro Fujikake; Yuma Okamoto; H Akiko Popiel; Yusuke Hatanaka; Morio Ueyama; Mari Suzuki; Sébastien Gaumer; Miho Murata; Keiji Wada; Yoshitaka Nagai
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

9.  CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.

Authors:  Nicole F Liachko; Pamela J McMillan; Chris R Guthrie; Thomas D Bird; James B Leverenz; Brian C Kraemer
Journal:  Ann Neurol       Date:  2013-07-08       Impact factor: 10.422

10.  Astrocytic TDP-43 pathology in Alexander disease.

Authors:  Adam K Walker; Christine M LaPash Daniels; James E Goldman; John Q Trojanowski; Virginia M-Y Lee; Albee Messing
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.